China Conglomerate Fosun Sees Profit Rebound Next Year

The video discusses the impact of COVID-19 on business earnings, highlighting challenges in tourism and retail sectors. It outlines expectations for recovery and future business performance, emphasizing the role of healthcare advancements and vaccine development. The company is optimistic about the vaccine's availability and affordability, aiming for a global rollout by the end of the year.

What were the two main impacts of COVID-19 on the company's earnings?

• Tourism and retail sectors

• Healthcare and technology sectors

• Manufacturing and agriculture sectors

• Education and transportation sectors

How long has the company been investing in research and development for their healthcare business?

• 10 years

• 5 years

• 8 years

• 12 years

Which country is collaborating with the company on the COVID-19 vaccine?

• Germany

• Japan

• United States

• India

When is the COVID-19 vaccine expected to be commercially available in China?

• February or March

• December or January

• October or November

• August or September

What is the company's primary consideration in pricing the COVID-19 vaccine?

• Exclusive distribution rights

• Affordability for most people

• Government subsidies

• Maximizing profit